ATC codes: P01AB01
Trichomoniasis ICD11 code: 1A92
Medicine type
Chemical agent
Antibiotic groups
List type
Oral > Liquid: 200 mg per 5 mL (as benzoate)
Local > Rectal > Suppository: 500 mg suppository ; 1 g suppository
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Oral > Solid > tablet: 200 mg ; 250 mg ; 400 mg ; 500 mg
EML status history
First added in 2017 (TRS 1006)
Changed in 2023 (TRS 1049)
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Expert Committee recommendation
In consideration of the review of the age appropriateness of formulations of medicines on the EMLc, and the comparison report of the EML versus EMLc, the Expert Committee recommended changes to the EMLc for addition of new, age-appropriate formulations and strengths of existing essential medicines, deletion of unavailable or age-inappropriate formulations and strengths, and other listing modifications as proposed in the application. The Committee also endorsed the proposals for further review of the public health relevance and evidence for specific medicines for use in children for potential future consideration for inclusion on the EMLc. The Committee noted and welcomed the ongoing review being coordinated by the Secretariat for the remaining sections of the EMLc for consideration by the 2025 Expert Committee. As a result of the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the range of strengths of metronidazole tablets be replaced with reference to specific strengths on the EML and EMLc.
EML recommendations: Trichomoniasis
First choice
Second choice
First choice
Second choice